Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 68788-8487

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 68788-8487). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glipizide Extended-release 25mg (4632b4ec D2f1 40cc 8ef4 256413d8dbec 00)

Glipizide Extended-Release 2.5 mg tablet label from Preferred Pharmaceuticals Inc. The label indicates it is a generic for Glucotrol XL, with each extended-release tablet containing 2.63 mg of glipizide USP to provide a 2.5 mg dose. The label includes storage instructions, warnings, and directions for use in English and Spanish. Manufacturer listed as Unique Pharmaceutical Laboratories.*

FDA Label Image

Structural Formula (Structural Formula)

Chemical structure of Glipizide displayed as a molecular diagram illustrating atomic connections typical of this oral hypoglycemic agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.